Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Toll Biotech Co. Ltd. (beijing)

Clinical trials sponsored by Toll Biotech Co. Ltd. (beijing), explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill aims to tame rheumatoid arthritis pain and swelling Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

Can a new pill ease the hardening skin of systemic sclerosis?

Disease control Not yet recruiting

This phase II trial is testing an experimental tablet called TollB-001 in adults with systemic sclerosis, a rare autoimmune disease that causes skin thickening and can affect internal organs. The study aims to see whether the drug can improve skin symptoms and overall well-being …

Phase 2 • Sponsor: Toll Biotech Co. Ltd. (Beijing) • Aim: Disease control

Last updated Aug 06, 2026 00:00 UTC